Great West Life Assurance CO Madrigal Pharmaceuticals, Inc. Transaction History
Great West Life Assurance CO
- $57.4 Billion
- Q3 2024
A detailed history of Great West Life Assurance CO transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 1,289 shares of MDGL stock, worth $444,937. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,289
Previous 1,289
-0.0%
Holding current value
$444,937
Previous $361,000
24.1%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding MDGL
# of Institutions
298Shares Held
22MCall Options Held
819KPut Options Held
640K-
Janus Henderson Group PLC London, X02.48MShares$855 Million0.28% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$705 Million29.57% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$700 Million6.48% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$688 Million6.74% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$682 Million4.49% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.9B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...